María Sol Rodríguez

2PUBLICATIONS
11CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Dec 28, 2024
FGFR2-RUNX2 activation: An unexplored therapeutic pathway in luminal breast cancer related to tumor progression.

María S Rodriguez, Yamil D Mahmoud, Silvia Vanzulli

|Sep 19, 2023
The Beta2-adrenergic agonist salbutamol synergizes with paclitaxel on cell proliferation and tumor growth in triple negative breast cancer models.

Martina Jabloñski, María Sol Rodríguez, Ezequiel Mariano Rivero

Pageof 1

Frequent Collaborators

2 joint publications

Isabel Alicia Lüthy

2 joint publications

Cecilia Pérez Piñero

1 joint publications

Yamil D Mahmoud

1 joint publications

Silvia Vanzulli